MedTech Acquisition (OTCMKTS:MTACU) Stock Jumps 19.5% – Should You Buy?

MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) traded up 19.5% during mid-day trading on Friday. The company traded as high as $11.35 and last traded at $11.35. 1,900 shares changed hands during mid-day trading, an increase of 225% from the average daily volume of 585 shares. The stock had previously closed at $9.50.

MedTech Acquisition Trading Up 19.5%

The business has a 50-day moving average price of $11.35 and a 200-day moving average price of $11.35.

About MedTech Acquisition

(Get Free Report)

MedTech Acquisition is a special purpose acquisition company (SPAC) formed to identify and acquire or combine with a business in the healthcare, medical technology, or related sectors.

The company was established to raise capital through a public offering and use the proceeds for a future business combination. Until such a transaction is completed, it does not operate a conventional business and generally does not offer products or services of its own.

Publicly available information about MedTech Acquisition’s operations, geographic reach, and leadership is limited.

Featured Articles

Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.